Nutri-PEITC Jelly Significantly Improves Progression-Free Survival and Quality of Life in Patients with Advanced Oral and Oropharyngeal Cancer: A Blinded Randomized Placebo-Controlled Trial
<i>TP53</i> mutation is associated with cancer progression. Novel strategies to reboot p53 are required to stabilize the disease and improve survival. This randomized placebo-controlled trial investigated safety and efficacy of Nutri-PEITC Jelly (a texture-modified nutritious diet fortif...
Main Authors: | Aroonwan Lam-Ubol, Jirasak Sukhaboon, Withee Rasio, Peerawitch Tupwongse, Thapana Tangshewinsirikul, Dunyaporn Trachootham |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/9/7824 |
Similar Items
-
Direct Inhibition of GSDMD by PEITC Reduces Hepatocyte Pyroptosis and Alleviates Acute Liver Injury in Mice
by: Jie Wang, et al.
Published: (2022-01-01) -
PEITC: A resounding molecule averts metastasis in breast cancer cells in vitro by regulating PKCδ/Aurora A interplay
by: Souvick Biswas, et al.
Published: (2022-11-01) -
Synergistic Microbicidal Effect of AUR and PEITC Against Staphylococcus aureus Skin Infection
by: Haoran Chen, et al.
Published: (2022-06-01) -
Nutritional Assessment of Ready-to-Eat Salads in German Supermarkets: Comparison of the nutriRECIPE-Index and the Nutri-Score
by: Laura Schlarbaum, et al.
Published: (2022-12-01) -
Targeted anti-cancer therapy: Co-delivery of VEGF siRNA and Phenethyl isothiocyanate (PEITC) via cRGD-modified lipid nanoparticles for enhanced anti-angiogenic efficacy
by: Bao Li, et al.
Published: (2024-04-01)